We can help you starting from morphological diagnosis up to the top of personalization in terms of prediction, prognosis, follow-up. Learn more about our genetic panel for the prediction of adverse effects in systemic chemotherapy. We are committed to provide you the best of accuracy in the minimum of time and our experts are always available to assist you in the further steps.
BRCA1 and BRCA2 somatic mutations and rearrangements
FISH on urothelial cells
Panel for lung cancer (EGFR, KRAS, BRAF, PIK3CA, NRAS, ALK, ERBB2, DDR2, MAP2K1, RET) and ALK Break-Apart and ROS 1 fusions by Fluorescent in situ hybridization method (FISH)
Panel for colon cancer (KRAS, BRAF, NRAS, PIK3CA)
Searching for 126 polymorphisms in 58 genes involved in the absorption, distribution, metabolism, elimination and toxicity of cancer chemotherapeutic agents.
Wide mutational panels for colorectal and lung cancer follow-up and early diagnosis
Test for immuno-oncology therapy
Expression of immune check points (PD-1, PD-L1, CTLA-4)
Expression of mismatch repair genes (MLH1, MSH2, MSH6, PMS2)
Tumor Mutation Burden (170 genes DNA and RNA)